[1]
Hopirtean, C. and Nagy, V. 2018. Optimizing the use of anti VEGF targeted therapies in patients with metastatic colorectal cancer: review of literature. Medicine and Pharmacy Reports. 91, 1 (Jan. 2018), 12-17. DOI:https://doi.org/10.15386/cjmed-881.